Erythromycin acistrate

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameErythromycin acistrate
Drug Alias NameErystratErasis
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFinland
Original Approved Date1987/01/01
Country/TerritoryFinland
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesOrion Corp
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeD10AF02J01FA01S01AA17
Related LinksKEGG